Teoxane Laboratories
Sophie Delhomme is a seasoned professional in clinical project management with extensive experience in managing Phase I clinical trials and supporting various clinical programs. Currently serving as a Senior Clinical Project Manager at Teoxane Laboratories since November 2023, Sophie previously contributed to the Drugs for Neglected Diseases initiative (DNDi) from May 2013 to October 2023, managing early clinical development activities. Prior roles include Clinical Project Manager at Merck Serono, where talent was demonstrated in early clinical development and Phase I trials, as well as positions at Covance CLS, Amtech Chimie, and the Université de Geneve. Sophie holds a Post-Graduate Degree in Biomolecular Chemistry from Université Joseph Fourier (Grenoble I).
This person is not in any teams
This person is not in any offices
Teoxane Laboratories
1 followers
When Madame Valérie Taupin created TEOXANE Laboratories in Geneva in 2003, her vision was crystal clear: to satisfy the ever demanding aesthetic market with high performance, avant-garde products based on rigorous scientific research. Today our focus remains unchanged. We are dedicated to designing and manufacturing hyaluronic acid dermal fillers and skincare products, applying industry-leading expertise and high-quality standards. Building on a firm commitment to innovation and patient satisfaction, we have strengthened our presence. In 2023, TEOXANE has over 10 subsidiaries and is present in more than 95 countries worldwide. TEOXANE is now confirmed as a major player in aesthetic medicine and skincare, offering effective solutions to practitioners worldwide, helping women and men who want to look and feel their best at all times and help them maintain their beauty in the future. Our core values of Innovation, Culture of Excellence and Independence continue to set us apart and guide our ambitions.